Asthma and Airway Disease Research Center, University of Arizona, Tucson, AZ, United States.
Department of Immunobiology, The University of Arizona College of Medicine, Tucson, AZ, United States.
Front Immunol. 2023 Feb 21;14:1109001. doi: 10.3389/fimmu.2023.1109001. eCollection 2023.
Respiratory syncytial virus (RSV) and Rhinovirus (RV) infections are major triggers of severe lower respiratory illnesses (sLRI) in infants and children and are strongly associated with the subsequent development of asthma. Decades of research has focused on the role of type I interferons in antiviral immunity and ensuing airway diseases, however, recent findings have highlighted several novel aspects of the interferon response that merit further investigation. In this perspective, we discuss emerging roles of type I interferons in the pathogenesis of sLRI in children. We propose that variations in interferon response patterns exist as discrete endotypes, which operate locally in the airways and systemically through a lung-blood-bone marrow axis. We discuss new insights into the role of interferons in immune training, bacterial lysate immunotherapy, and allergen-specific immunotherapy. Interferons play complex and diverse roles in the pathogenesis of sLRI and later asthma, providing new directions for mechanistic studies and drug development.
呼吸道合胞病毒(RSV)和鼻病毒(RV)感染是婴儿和儿童严重下呼吸道疾病(sLRI)的主要诱因,并且与随后哮喘的发展密切相关。几十年来的研究一直集中在 I 型干扰素在抗病毒免疫和随后的气道疾病中的作用上,然而,最近的发现强调了干扰素反应的几个新方面,值得进一步研究。在这篇观点文章中,我们讨论了 I 型干扰素在儿童 sLRI 发病机制中的新作用。我们提出,干扰素反应模式的变化作为离散的表型存在,它们在气道局部和通过肺-血-骨髓轴系统发挥作用。我们讨论了干扰素在免疫训练、细菌裂解物免疫治疗和过敏原特异性免疫治疗中的作用的新见解。干扰素在 sLRI 及随后的哮喘发病机制中发挥着复杂而多样的作用,为机制研究和药物开发提供了新的方向。